Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 December 2019 | Story Thabo Kessah | Photo Rian Horn
UFS Qwaqwa Campus
Hundreds of international botanists will be attending the 46th SAAB Annual Conference on the Qwaqwa Campus.

The University of the Free State Qwaqwa Campus is gearing up to host the 46th Annual Conference of the South African Association of Botanists from 7 to 10 January 2020. Talking about the choice of venue, Chairperson of the Local Organising Committee, Dr Sandy-Lynn Steenhuisen, said the unique setting in the shadow of the Maloti-Drakensberg Mountains highlights the Qwaqwa Campus as a fantastic base for interdisciplinary montane studies. “This is the home of the Afromontane Research Unit (ARU), and it will also give the delegates an opportunity to explore a treasure trove of botanical diversity on a post-conference tour to the top of the Amphitheatre in the Northern Drakensberg,” she said.

International delegates

“The conference will be attended by approximately 250 delegates representing at least 10 countries.  We are very excited to host two international and two national plenaries, namely Prof Peter Linder (University of Zürich), Prof Felipe Amorim (São Paulo State University – UNESP), Prof Annah Moteetee (University of Johannesburg), and our Young Botanist award winner from SAAB 2019, Ryan Rattray from GeneLethu Laboratories.”

SAAB 2020 is open to all researchers, industry partners, and citizen scientists from any botanical field. “The theme will embrace Qwaqwa’s cultural heritage by using the Sesotho phrase ‘Dimela ke bophelo’, which translates to ‘Plants are life’. This theme emphasises the dependence of all earthly life on plants. Delegates are offered the opportunity to book residence accommodation adjacent to the conference venue, and our conference organisers, XL Millennium, are eager to help with registration and any travel arrangements,” she added.

Botanists to be awarded

The conference will also be honouring botanists for their lifetime contributions to the field of plant sciences with the awarding of gold and silver medals, and the best doctoral thesis from the previous year with a bronze medal. These will be awarded during the gala dinner at the end of the conference.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept